ZHANG Min, TAN Zhen, MA Yan, TAO Jin-hui, JIN Li, WANG Guo-sheng, LI Xiao-mei, SHAN Shu-guang, LI Xiang-pei. Efficacy and safety evaluation of tocilizumab combined with cDMARDs in the treatment of refractory rheumatoid arthritis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2018, 22(2): 211-214. doi: 10.16462/j.cnki.zhjbkz.2018.02.027
| Citation:
|
ZHANG Min, TAN Zhen, MA Yan, TAO Jin-hui, JIN Li, WANG Guo-sheng, LI Xiao-mei, SHAN Shu-guang, LI Xiang-pei. Efficacy and safety evaluation of tocilizumab combined with cDMARDs in the treatment of refractory rheumatoid arthritis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2018, 22(2): 211-214. doi: 10.16462/j.cnki.zhjbkz.2018.02.027
|
ZHANG Min, TAN Zhen, MA Yan, TAO Jin-hui, JIN Li, WANG Guo-sheng, LI Xiao-mei, SHAN Shu-guang, LI Xiang-pei. Efficacy and safety evaluation of tocilizumab combined with cDMARDs in the treatment of refractory rheumatoid arthritis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2018, 22(2): 211-214. doi: 10.16462/j.cnki.zhjbkz.2018.02.027
| Citation:
|
ZHANG Min, TAN Zhen, MA Yan, TAO Jin-hui, JIN Li, WANG Guo-sheng, LI Xiao-mei, SHAN Shu-guang, LI Xiang-pei. Efficacy and safety evaluation of tocilizumab combined with cDMARDs in the treatment of refractory rheumatoid arthritis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2018, 22(2): 211-214. doi: 10.16462/j.cnki.zhjbkz.2018.02.027
|
Efficacy and safety evaluation of tocilizumab combined with cDMARDs in the treatment of refractory rheumatoid arthritis
- Received Date: 2017-05-20
- Rev Recd Date:
2017-08-09
DownLoad: